Physician profile
Alison Elmquist
NPI 1285627984
$2,245.98
in general payments reported to CMS, 2019-2025
34 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $232 · 2021: $277 · 2022: $332 · 2023: $411 · 2024: $425 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.31 | 2019-2023 | |
| Pfizer INC. | $188.87 | 2019-2025 | |
| Dilon Technologies, INC. | $164.58 | 2024 | Hemoblast Bellows |
| Ascend Therapeutics US, LLC | $163.98 | 2021 | |
| Hologic Sales and Service, LLC | $141.67 | 2019-2024 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Amgen INC. | $133.12 | 2019-2025 | Evenity, Prolia |
| Exeltis, USA INC. | $124.85 | 2019-2023 | Slynd |
| Astellas Pharma US INC | $92.11 | 2021-2024 | Veozah |
| Medtronic, INC. | $82.56 | 2023-2024 | Ligasure, V-Loc 180 |
| Mayne Pharma Commercial LLC | $80.05 | 2022-2023 | |
| Smith+Nephew, INC. | $66.91 | 2019-2021 | |
| Millicent US INC | $66.68 | 2020-2024 | Intrarosa, Femring |
| Merck Sharp & Dohme LLC | $59.00 | 2020-2023 | Gardasil 9 |
| Sumitomo Pharma America, INC. | $47.05 | 2023-2024 | Myfembree |
| Avion Pharmaceuticals | $46.66 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $38.93 | 2024-2025 | Nexplanon |
| Pacira Pharmaceuticals Incorporated | $38.19 | 2019-2023 | Exparel |
| Therapeuticsmd, INC. | $37.34 | 2019-2020 | |
| Radius Health, INC. | $31.44 | 2019 | |
| Ethicon US, LLC | $29.33 | 2025 | Harmonic |
| Amag Pharmaceuticals, INC. | $27.71 | 2019-2020 | |
| Allergan, INC. | $25.02 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $23.90 | 2019 | |
| Innovation Technologies INC | $23.82 | 2023 | Irrisept |
| Boston Scientific Corporation | $23.77 | 2025 | General - Female Sui |
| Bayer Healthcare Pharmaceuticals INC. | $22.07 | 2022 | |
| Duchesnay USA Incorporated | $20.00 | 2022 | |
| Agile Therapeutics, INC. | $17.91 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.76 | 2020 | |
| Coopersurgical, INC. | $15.86 | 2019 | |
| Baxter Healthcare | $15.84 | 2025 | Perclot |
| Aspira Women'S Health INC | $12.03 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.08 | 2019 | |
| Meditrina | $8.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Elmquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.